These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19154901

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.
    Lopci E, Toschi L, Grizzi F, Rahal D, Olivari L, Castino GF, Marchetti S, Cortese N, Qehajaj D, Pistillo D, Alloisio M, Roncalli M, Allavena P, Santoro A, Marchesi F, Chiti A.
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1954-61. PubMed ID: 27251642
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy.
    Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML.
    Radiat Oncol; 2017 Jan 05; 12(1):4. PubMed ID: 28057034
    [Abstract] [Full Text] [Related]

  • 25. The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.
    Zuo M, Yao L, Wen L, Shen J, Zhang N, Bai T, Huang Q.
    World J Surg Oncol; 2021 Sep 01; 19(1):262. PubMed ID: 34470640
    [Abstract] [Full Text] [Related]

  • 26. Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic 18F Fluorodeoxyglucose PET.
    Meijer TWH, de Geus-Oei LF, Visser EP, Oyen WJG, Looijen-Salamon MG, Visvikis D, Verhagen AFTM, Bussink J, Vriens D.
    Radiology; 2017 May 01; 283(2):547-559. PubMed ID: 27846378
    [Abstract] [Full Text] [Related]

  • 27. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
    Messerli M, Kotasidis F, Burger IA, Ferraro DA, Muehlematter UJ, Weyermann C, Kenkel D, von Schulthess GK, Kaufmann PA, Huellner MW.
    Br J Radiol; 2019 Apr 01; 92(1096):20180792. PubMed ID: 30673302
    [Abstract] [Full Text] [Related]

  • 28. Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer.
    Takenaka T, Yano T, Ito K, Morodomi Y, Miura N, Kawano D, Shoji F, Abe K, Honda H, Maehara Y.
    J Surg Oncol; 2009 Dec 15; 100(8):688-92. PubMed ID: 19731260
    [Abstract] [Full Text] [Related]

  • 29. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 15; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 30. Prognostic impact of 18F-FDG uptake on PET in non-small cell lung cancer patients with postoperative recurrence following platinum-based chemotherapy.
    Kaira K, Yamamoto N, Kenmotsu H, Murakami H, Ono A, Naito T, Endo M, Takahashi T.
    Respir Investig; 2014 Mar 15; 52(2):121-8. PubMed ID: 24636268
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA.
    Chest; 2006 Feb 15; 129(2):393-401. PubMed ID: 16478857
    [Abstract] [Full Text] [Related]

  • 32. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S.
    Ann Nucl Med; 2015 Dec 15; 29(10):897-905. PubMed ID: 26342592
    [Abstract] [Full Text] [Related]

  • 33. Quantitative CT density histogram values and standardized uptake values of FDG-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung.
    Tsubakimoto M, Yamashiro T, Tamashiro Y, Murayama S.
    Eur J Radiol; 2018 Mar 15; 100():108-115. PubMed ID: 29496067
    [Abstract] [Full Text] [Related]

  • 34. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
    Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ.
    Lung Cancer; 2002 Feb 15; 35(2):179-87. PubMed ID: 11804691
    [Abstract] [Full Text] [Related]

  • 35. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J, Li C, Hu M, Lu J, Shi X, Xing L, Sun X, Fu Z, Yu J, Meng X.
    Medicine (Baltimore); 2015 May 15; 94(17):e678. PubMed ID: 25929896
    [Abstract] [Full Text] [Related]

  • 36. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T, Bundschuh RA, Andratschke N, Mayer B, Specht HM, Papp L, Zsótér N, Essler M.
    Radiat Oncol; 2015 Apr 22; 10():100. PubMed ID: 25900186
    [Abstract] [Full Text] [Related]

  • 37. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
    Sun JS, Park KJ, Sheen SS, Yoon JK, Yoon SN, Lee KB, Hwang SC.
    Lung Cancer; 2009 Nov 22; 66(2):205-10. PubMed ID: 19203812
    [Abstract] [Full Text] [Related]

  • 38. Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
    Even AJG, Reymen B, La Fontaine MD, Das M, Jochems A, Mottaghy FM, Belderbos JSA, De Ruysscher D, Lambin P, van Elmpt W.
    Acta Oncol; 2017 Nov 22; 56(11):1591-1596. PubMed ID: 28840770
    [Abstract] [Full Text] [Related]

  • 39. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep 22; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 40. [The immunohistochemical expression of cyclin B1 is associated with higher SUV in 18F-FDG-PET in non-small cell lung cancer patients. Initial results].
    Sánchez Salmón A, Garrido M, Abdulkader I, Gude F, León L, Ruibal A.
    Rev Esp Med Nucl; 2009 Sep 22; 28(2):63-5. PubMed ID: 19406050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.